QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 jp-morgan-maintains-neutral-on-progyny-raises-price-target-to-25

JP Morgan analyst Anne Samuel maintains Progyny (NASDAQ:PGNY) with a Neutral and raises the price target from $23 to $25.

 canaccord-genuity-maintains-hold-on-progyny-raises-price-target-to-23

Canaccord Genuity analyst Richard Close maintains Progyny (NASDAQ:PGNY) with a Hold and raises the price target from $21 to ...

 cantor-fitzgerald-maintains-overweight-on-progyny-raises-price-target-to-28

Cantor Fitzgerald analyst Sarah James maintains Progyny (NASDAQ:PGNY) with a Overweight and raises the price target from $26...

 progyny-raises-fy2025-adj-eps-guidance-from-154-164-to-170-178-vs-054-est

Progyny (NASDAQ:PGNY) raises FY2025 Adj EPS guidance from $1.54-$1.64 to $1.70-$1.78 vs $0.54 analyst estimate..

 progyny-sees-q3-sales-290000m-305000m-vs-290721m-est

Progyny (NASDAQ:PGNY) sees Q3 sales of $290.000 million-$305.000 million vs $290.721 million analyst estimate.

 progyny-raises-fy2025-sales-guidance-from-1185b-1235b-to-1235b-1270b-vs-1225b-est

Progyny (NASDAQ:PGNY) raises FY2025 sales outlook from $1.185 billion-$1.235 billion to $1.235 billion-$1.270 billion vs $1.225...

 progyny-q2-adj-eps-048-beats-016-estimate-sales-332874m-beat-315439m-estimate

Progyny (NASDAQ:PGNY) reported quarterly earnings of $0.48 per share which beat the analyst consensus estimate of $0.16 by 201....

 truist-securities-maintains-hold-on-progyny-raises-price-target-to-27

Truist Securities analyst Jailendra Singh maintains Progyny (NASDAQ:PGNY) with a Hold and raises the price target from $24 t...

 leerink-partners-upgrades-progyny-to-outperform-announces-28-price-target

Leerink Partners analyst Michael Cherny upgrades Progyny (NASDAQ:PGNY) from Market Perform to Outperform and announces $28 p...

 canaccord-genuity-maintains-hold-on-progyny-lowers-price-target-to-21

Canaccord Genuity analyst Richard Close maintains Progyny (NASDAQ:PGNY) with a Hold and lowers the price target from $23 to ...

 progyny-sees-q2-adj-eps-040-043-vs-018-est-sees-sales-310000m-325000m-vs-30801m-est

Progyny (NASDAQ:PGNY) is looking for Q2 Adj EPS of $0.40-$0.43 vs $0.18 analyst estimate. sees sales of $310.000 million-$325.0...

 progyny-sees-q2-gaap-eps-013-016-vs-016-est

Progyny (NASDAQ:PGNY) is looking for Q2 GAAP EPS of $0.13-$0.16 vs $0.16 analyst estimate..

 progyny-lowers-fy2025-gaap-eps-guidance-from-049-059-to-046-056-vs-059-est

Progyny (NASDAQ:PGNY) lowers FY2025 GAAP EPS guidance from $0.49-$0.59 to $0.46-$0.56 vs $0.59 analyst estimate..

 progyny-raises-fy2025-adj-eps-guidance-from-152-162-to-154-164-vs-059-est-raises-fy2025-sales-guidance-from-118b-123b-to-119b-124b-vs-121b-est

Progyny (NASDAQ:PGNY) raises FY2025 Adj EPS guidance from $1.52-$1.62 to $1.54-$1.64 vs $0.59 analyst estimate. Raises FY2025 s...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION